StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3076% below fair value
$8.47+0.05 (+0.59%)

Close on Nov 17, 2026Market cap $3.17BP/E –Yield –

Bausch Health Companies price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Bausch Health Companies's price to book ratio was 21.4× on Apr 30, 2021, against 6.0× a year earlier. Over the last 5 years it ranged from 0.9× to 21.4×, with a median of 2.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Apr 30, 202121.4×+8.8
2020Dec 31, 202012.6×+8.3
2019Dec 31, 20194.2×+2.2
2018Dec 31, 20182.0×+0.7
2017Dec 29, 20171.4×+0.1
2016Dec 30, 20161.2×−4.3
2015Dec 31, 20155.5×−3.8
2014Dec 31, 20149.3×+1.4
2013Dec 31, 20137.9×+3.1
2012Dec 31, 20124.8×+1.2
2011Dec 30, 20113.6×−3.0
2010Jul 30, 20106.6×–

More Bausch Health Companies figures

See a number that looks wrong?